Robert West

Publications

• Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
  Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., & Diehn, M. (2015). Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 107(10).
• The prognostic landscape of genes and infiltrating immune cells across human cancers
  Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., & Alizadeh, A. A. (2015). The prognostic landscape of genes and infiltrating immune cells across human cancers. NATURE MEDICINE, 21(8), 938-945.
• Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
  Guo, X., Jo, V. Y., Mills, A. M., Zhu, S. X., Lee, C.-H., & van de Rijn, M. (2015). Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clinical cancer research , 21(15), 3501-3511.
• Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling Riordan, D. P., Varma, S., West, R. B., & Brown, P. O. (2015). Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. PLOS ONE, 10(7).
  
• Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors Padda, S. K., Riess, J. W., Schwartz, E. J., Tian, L., Kohrt, H. E., & Wakelee, H. A. (2015). Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors. JOURNAL OF THORACIC ONCOLOGY, 10(3), 500-508.
  
• Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets Ang, D., Ballard, M., Beadling, C., Warrick, A., Schilling, A., & Troxell, M. L. (2015). Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 23(2), 97-103.
  
• GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. Riess, J. W., West, R., Dean, M., Klimowicz, A. C., Neal, J. W., & Wakelee, H. A. (2015). GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. Anticancer research, 35(2), 669-676.
  
• Pemetrexed in patients with thymic malignancies previously treated with chemotherapy Liang, Y., Padda, S. K., Riess, J. W., West, R. B., Neal, J. W., & Wakelee, H. A. (2015). Pemetrexed in patients with thymic malignancies previously treated with chemotherapy. LUNG CANCER, 87(1), 34-38.
  
• Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. Afghahi, A., Forgó, E., Mitani, A. A., Desai, M., Varma, S., & West, R. B. (2015). Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. Breast cancer research , 17, 108-?.
  
• Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. Riordan, D. P., Varma, S., West, R. B., & Brown, P. O. (2015). Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. PloS one, 10(7).
  
• Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia. Weng, Z., Spies, N., Zhu, S. X., Newburger, D. E., Kashef-Haghighi, D., & West, R. B. (2015). Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia. Genome medicine, 7(1), 28-?.
  
• Fast and scalable inference of multi-sample cancer lineages. Popic, V., Salari, R., Hajirasouliha, I., Kashef-Haghighi, D., West, R. B., & Batzoglou, S. (2015). Fast and scalable inference of multi-sample cancer lineages. Genome biology, 16(1), 91-?.
  
• Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis Howarth, M. M., Simpson, D., Ngok, S. P., Nieves, B., Chen, R., & Sweet-Cordero, E. A. (2014). Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. JOURNAL OF CLINICAL INVESTIGATION, 124(12), 5275-5290.
  
• Identification of recurrent SMO and BRAF mutations in ameloblastomas Sweeney, R. T., McClary, A. C., Myers, B. R., Biscocho, J., Neahring, L., & West, R. B. (2014). Identification of recurrent SMO and BRAF mutations in ameloblastomas. NATURE GENETICS, 46(7), 722-725.
  
• Identification of recurrent SMO and BRAF mutations in ameloblastomas. Sweeney, R. T., McClary, A. C., Myers, B. R., Biscocho, J., Neahring, L., & West, R. B. (2014). Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nature genetics, 46(7), 722-725.
  
• Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients Lin, Z., Khong, B., Kwok, S., Cao, H., West, R. B., & Kong, C. S. (2014). Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 36(5), 709-714.
  
• Stromal signatures in endometrioid endometrial carcinomas Espinosa, I., Catasus, L., D'angelo, E., Mozos, A., Pedrola, N., & Prat, J. (2014). Stromal signatures in endometrioid endometrial carcinomas. MODERN PATHOLOGY, 27(4), 631-639.
  
• Stromal responses among carcinomas--response. West, R. B., van de Rijn, M., & Chen, J. L. (2014). Stromal responses among carcinomas--response. Clinical cancer research , 20(5), 1397-?.
  
• Discovery of recurrent structural variants in nasopharyngeal carcinoma Valouev, A., Weng, Z., Sweeney, R. T., Varma, S., Quynh-Thu Le, Q. T., & West, R. B. (2014). Discovery of recurrent structural variants in nasopharyngeal carcinoma. GENOME RESEARCH, 24(2), 300-309.
  
• NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. (2014). NF-kappa B protein expression associates with F-18-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism. LUNG CANCER, 83(2), 189-196.
  
• A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions Brunner, A. L., Li, J., Guo, X., Sweeney, R. T., Varma, S., & West, R. B. (2014). A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. GENOME BIOLOGY, 15(5).
  
• A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Brunner, A. L., Li, J., Guo, X., Sweeney, R. T., Varma, S., & West, R. B. (2014). A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome biology, 15(5), R71-?.
  
• Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation Lee, C. Y.-F., Lin, Y., Bratman, S. V., Feng, W., Kuo, A. H., & Diehn, M. (2014). Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation. CANCER RESEARCH, 74(1), 341-352.
  
• Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities van de Rijn, M., Guo, X., Sweeney, R. T., Beck, A. H., & West, R. B. (2014). Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities. HISTOPATHOLOGY, 64(1), 163-170.
  
• MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions Clay, M. R., Varma, S., & West, R. B. (2013). MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions. HUMAN PATHOLOGY, 44(12), 2837-2844.
  
• Inference of tumor phylogenies with improved somatic mutation discovery. Salari, R., Saleh, S. S., Kashef-Haghighi, D., Khavari, D., Newburger, D. E., & Batzoglou, S. (2013). Inference of tumor phylogenies with improved somatic mutation discovery. Journal of computational biology , 20(11), 933-944.
  
• Inference of Tumor Phylogenies with Improved Somatic Mutation Discovery Salari, R., Saleh, S. S., Kashef-Haghighi, D., Khavari, D., Newburger, D. E., & Batzoglou, S. (2013). Inference of Tumor Phylogenies with Improved Somatic Mutation Discovery. JOURNAL OF COMPUTATIONAL BIOLOGY, 20(11), 933-944.
  
• Stromal Responses among Common Carcinomas Correlated with Clinicopathologic Features Chen, J. Ly., Espinosa, I., Lin, A. Y., Liao, O. Yw., van de Rijn, M., & West, R. B. (2013). Stromal Responses among Common Carcinomas Correlated with Clinicopathologic Features. CLINICAL CANCER RESEARCH, 19(18), 5127-5135.
  
• Integrative Bioinformatics Links HNF1B with Clear Cell Carcinoma and Tumor-Associated Thrombosis Cuff, J., Salari, K., Clarke, N., Esheba, G. E., Forster, A. D., & Pollack, J. R. (2013). Integrative Bioinformatics Links HNF1B with Clear Cell Carcinoma and Tumor-Associated Thrombosis. PLOS ONE, 8(9).
  
• Genome evolution during progression to breast cancer Newburger, D. E., Kashef-Haghighi, D., Weng, Z., Salari, R., Sweeney, R. T., & Sidow, A. (2013). Genome evolution during progression to breast cancer. GENOME RESEARCH, 23(7), 1097-1108.
  
• Desktop Transcriptome Sequencing From Archival Tissue to Identify Clinically Relevant Translocations Sweeney, R. T., Zhang, B., Zhu, S. X., Varma, S., Smith, K. S., & West, R. B. (2013). Desktop Transcriptome Sequencing From Archival Tissue to Identify Clinically Relevant Translocations. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(6), 796-803.
  
• Reconsidering the Diagnostic and Prognostic Utility of LN-2 for Undifferentiated Pleomorphic Sarcoma and Atypical Fibroxanthoma Hollmig, S. T., Rieger, K. E., Henderson, M. T., West, R. B., & Sundram, U. N. (2013). Reconsidering the Diagnostic and Prognostic Utility of LN-2 for Undifferentiated Pleomorphic Sarcoma and Atypical Fibroxanthoma. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 35(2), 176-179.
  
• Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types Giacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., & Pollack, J. R. (2013). Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types. PLOS GENETICS, 9(4).
  
• Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. Giacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., & Pollack, J. R. (2013). Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. PLoS genetics, 9(4).
  
• Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth Edris, B., Willingham, S. B., Weiskopf, K., Volkmer, A. K., Volkmer, J.-P., & van de Rijn, M. (2013). Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(9), 3501-3506.
  
• ROR2 Expression in Breast Cancer Guo, X., Sweeny, P., Varma, S., Montgomery, K., West, R. B., & van de Rijn, M. (2013). ROR2 Expression in Breast Cancer. LABORATORY INVESTIGATION, 93, 45A-45A.
  
• Desktop Transcriptome Sequencing from Archival Tissue To Identify Clinically Relevant Translocations SWEENEY, R. T., Zhang, B., Zhu, S. X., Varma, S., Smith, K., & West, R. B. (2013). Desktop Transcriptome Sequencing from Archival Tissue To Identify Clinically Relevant Translocations. LABORATORY INVESTIGATION, 93, 438A-438A.
  
• Two New Stromal Signatures Stratify Breast Cancers with Different Prognosis Guo, X., Zhu, S. X., Montgomery, K., van de Rijn, M., & West, R. B. (2013). Two New Stromal Signatures Stratify Breast Cancers with Different Prognosis. MODERN PATHOLOGY, 26, 434A-435A.
  
• Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. Cuff, J., Salari, K., Clarke, N., Esheba, G. E., Forster, A. D., & Pollack, J. R. (2013). Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PloS one, 8(9).
  
• Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer Guo, X., Zhu, S. X., Brunner, A. L., van de Rijn, M., & West, R. B. (2013). Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer. BREAST CANCER RESEARCH, 15(6).
  
• Biphasic Papillary and Lobular Breast Carcinoma With PIK3CA and IDH1 Mutations Ang, D., VanSandt, A. M., Beadling, C., Warrick, A., West, R. B., & Troxell, M. L. (2012). Biphasic Papillary and Lobular Breast Carcinoma With PIK3CA and IDH1 Mutations. DIAGNOSTIC MOLECULAR PATHOLOGY, 21(4), 221-224.
  
• beta-Adrenergic receptor expression in vascular tumors Chisholm, K. M., Chang, K. W., Truong, M. T., Kwok, S., West, R. B., & Heerema-McKenney, A. E. (2012). beta-Adrenergic receptor expression in vascular tumors. MODERN PATHOLOGY, 25(11), 1446-1451.
  
• TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma Ohgami, R. S., Zhao, S., Ohgami, J. K., Leavitt, M. O., Zehnder, J. L., & Warnke, R. A. (2012). TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(11), 1619-1628.
  
• Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma Chisholm, K. M., Wan, Y., Li, R., Montgomery, K. D., Chang, H. Y., & West, R. B. (2012). Detection of Long Non-Coding RNA in Archival Tissue: Correlation with Polycomb Protein Expression in Primary and Metastatic Breast Carcinoma. PLOS ONE, 7(10).
  
• Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms Karamchandani, J. R., Nielsen, T. O., van de Rijn, M., & West, R. B. (2012). Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(5), 445-450.
  
• Pathologic Features and Immunophenotype of Estrogen Receptor-positive Breast Cancers in BRCA1 Mutation Carriers Kaplan, J. S., Schnitt, S. J., Collins, L. C., Wang, Y., Garber, J. E., & Tung, N. M. (2012). Pathologic Features and Immunophenotype of Estrogen Receptor-positive Breast Cancers in BRCA1 Mutation Carriers. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(10), 1483-1488.
  
• Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome Henry, E., Villalobos, V., Million, L., Jensen, K. C., West, R., & Telli, M. L. (2012). Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni Syndrome. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(8), 939-942.
  
• Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions Troxell, M. L., Brunner, A. L., Neff, T., Warrick, A., Beadling, C., & West, R. B. (2012). Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. MODERN PATHOLOGY, 25(7), 930-937.
  
• ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour Edris, B., Espinosa, I., Muehlenberg, T., Mikels, A., Lee, C.-H., & van de Rijn, M. (2012). ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. JOURNAL OF PATHOLOGY, 227(2), 223-233.
  
• Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma Edris, B., Weiskopf, K., Volkmer, A. K., Volkmer, J.-P., Willingham, S. B., & van de Rijn, M. (2012). Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6656-6661.
  
• Identification of Pathogens in Archival Tissues Using a High-Throughput Sequencing Approach, 35EQ SWEENEY, R. T., Brunner, A. L., Montgomery, K. D., Zhu, S. X., Kong, C., & West, R. B. (2012). Identification of Pathogens in Archival Tissues Using a High-Throughput Sequencing Approach, 35EQ. LABORATORY INVESTIGATION, 92, 467A-467A.
  
• Identification of Pathogens in Archival Tissues Using a High-Throughput Sequencing Approach, 3SEQ SWEENEY, R. T., Brunner, A. L., Montgomery, K. D., Zhu, S. X., Kong, C., & West, R. B. (2012). Identification of Pathogens in Archival Tissues Using a High-Throughput Sequencing Approach, 3SEQ. MODERN PATHOLOGY, 25, 467A-467A.
  
• 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma Lee, C.-H., Ou, W.- bin, Marino-Enriquez, A., Zhu, M., Mayeda, M., & Fletcher, J. A. (2012). 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(3), 929-934.
  
• Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers Brunner, A. L., Beck, A. H., Edris, B., Sweeney, R. T., Zhu, S. X., & West, R. B. (2012). Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. GENOME BIOLOGY, 13(8).
  
• Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma. Edris, B., Fletcher, J. A., West, R. B., van de Rijn, M., & Beck, A. H. (2012). Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma. Sarcoma, 2012, 805614-?.
  
• Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Brunner, A. L., Beck, A. H., Edris, B., Sweeney, R. T., Zhu, S. X., & West, R. B. (2012). Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome biology, 13(8), R75-?.
  
• Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target Colombo, C., Creighton, C. J., Ghadimi, M. P., Bolshakov, S., Warneke, C. L., & Lev, D. (2011). Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. JOURNAL OF PATHOLOGY, 225(4), 574-582.
  
• Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival Beck, A. H., Sangoi, A. R., Leung, S., Marinelli, R. J., Nielsen, T. O., & Koller, D. (2011). Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival. SCIENCE TRANSLATIONAL MEDICINE, 3(108).
  
• CSF1 Expression in Nongynecological Leiomyosarcoma Is Associated with Increased Tumor Angiogenesis Espinosa, I., Edris, B., Lee, C.-H., Cheng, H. W., Gilks, C. B., & van de Rijn, M. (2011). CSF1 Expression in Nongynecological Leiomyosarcoma Is Associated with Increased Tumor Angiogenesis. AMERICAN JOURNAL OF PATHOLOGY, 179(4), 2100-2107.
  
• Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma Tanas, M. R., Sboner, A., Oliveira, A. M., Erickson-Johnson, M. R., Hespelt, J., & Rubin, B. P. (2011). Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma. SCIENCE TRANSLATIONAL MEDICINE, 3(98).
  
• Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases Sangoi, A. R., Fujiwara, M., West, R. B., Montgomery, K. D., Bonventre, J. V., & McKenney, J. K. (2011). Immunohistochemical Distinction of Primary Adrenal Cortical Lesions From Metastatic Clear Cell Renal Cell Carcinoma: A Study of 248 Cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(5), 678-686.
  
• Expression of Subtype-Specific Group 1 Leiomyosarcoma Markers in a Wide Variety of Sarcomas by Gene Expression Analysis and Immunohistochemistry Mills, A. M., Beck, A. H., Montgomery, K. D., Zhu, S. X., Espinosa, I., & West, R. B. (2011). Expression of Subtype-Specific Group 1 Leiomyosarcoma Markers in a Wide Variety of Sarcomas by Gene Expression Analysis and Immunohistochemistry. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(4), 583-589.
  
• Endogenous Versus Tumor-Specific Host Response to Breast Carcinoma: A Study of Stromal Response in Synchronous Breast Primaries and Biopsy Site Changes Wu, J. M., Beck, A. H., Pate, L. L., Witten, D., Zhu, S. X., & West, R. B. (2011). Endogenous Versus Tumor-Specific Host Response to Breast Carcinoma: A Study of Stromal Response in Synchronous Breast Primaries and Biopsy Site Changes. CLINICAL CANCER RESEARCH, 17(3), 437-446.
  
• PAX8 and WT1 Are Superior to PAX2 and BRST2 in Distinguishing Mullerian Tract Tumors from Breast Carcinomas DiMaio, M. A., Beck, A. H., Montgomery, K. D., West, R. B., Longacre, T. A., & Kong, C. S. (2011). PAX8 and WT1 Are Superior to PAX2 and BRST2 in Distinguishing Mullerian Tract Tumors from Breast Carcinomas. MODERN PATHOLOGY, 24, 243A-243A.
  
• PAX8 and WT1 Are Superior to PAX2 and BRST2 in Distinguishing Mullerian Tract Tumors from Breast Carcinomas. DiMaio, M. A., Beck, A. H., Montgomery, K. D., West, R. B., Longacre, T. A., & Kong, C. S. (2011). PAX8 and WT1 Are Superior to PAX2 and BRST2 in Distinguishing Mullerian Tract Tumors from Breast Carcinomas. LABORATORY INVESTIGATION, 91, 243A-243A.
  
• Computational Image Analysis Identifies New Morphologic Features That Predict Breast Cancer Outcome. Beck, A. H., West, R. B., van De Vijver, M., & Koller, D. (2011). Computational Image Analysis Identifies New Morphologic Features That Predict Breast Cancer Outcome. MODERN PATHOLOGY, 24, 28A-28A.
  
• CSF1-Response Signature Is Associated with Tumor Angiogenesis in Non-Gynecological Leiomyosarcoma Espinosa, I., Beck, A., Edris, B., Lee, C.-H., West, R., & van de Rijn, M. (2011). CSF1-Response Signature Is Associated with Tumor Angiogenesis in Non-Gynecological Leiomyosarcoma. MODERN PATHOLOGY, 24, 13A-13A.
  
• CSF1-Response Signature Is Associated with Tumor Angiogenesis in Non-Gynecological Leiomyosarcoma Espinosa, I., Beck, A., Edris, B., Lee, C.-H., West, R., & van de Rijn, M. (2011). CSF1-Response Signature Is Associated with Tumor Angiogenesis in Non-Gynecological Leiomyosarcoma. LABORATORY INVESTIGATION, 91, 13A-13A.
  
• Computational Image Analysis Identifies New Morphologic Features That Predict Breast Cancer Outcome Beck, A. H., West, R. B., van De Vijver, M., & Koller, D. (2011). Computational Image Analysis Identifies New Morphologic Features That Predict Breast Cancer Outcome. LABORATORY INVESTIGATION, 91, 28A-28A.
  
• The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study Ganjoo, K. N., Witten, D., Patel, M., Espinosa, I., La, T., & West, R. B. (2011). The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 34(1), 82-86.
  
• MYB Expression and Translocation in Adenoid Cystic Carcinomas and Other Salivary Gland Tumors With Clinicopathologic Correlation West, R. B., Kong, C., Clarke, N., Gilks, T., Lipsick, J. S., & Le, Q.-T. (2011). MYB Expression and Translocation in Adenoid Cystic Carcinomas and Other Salivary Gland Tumors With Clinicopathologic Correlation. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(1), 92-99.
  
• Variations in stromal signatures in breast and colorectal cancer metastases Webster, J. A., Beck, A. H., Sharma, M., Espinosa, I., Weigelt, B., & West, R. (2010). Variations in stromal signatures in breast and colorectal cancer metastases. JOURNAL OF PATHOLOGY, 222(2), 158-165.
  
• Expression Profiling in Soft Tissue Sarcomas With Emphasis on Synovial Sarcoma, Gastrointestinal Stromal Tumor, and Leiomyosarcoma West, R. B. (2010). Expression Profiling in Soft Tissue Sarcomas With Emphasis on Synovial Sarcoma, Gastrointestinal Stromal Tumor, and Leiomyosarcoma. ADVANCES IN ANATOMIC PATHOLOGY, 17(5), 366-373.
  
• Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ Sharma, M., Beck, A. H., Webster, J. A., Espinosa, I., Montgomery, K., & West, R. B. (2010). Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. BREAST CANCER RESEARCH AND TREATMENT, 123(2), 397-404.
  
• DOG1 for the Diagnosis of Gastrointestinal Stromal Tumor (GIST): Comparison Between 2 Different Antibodies Lopes, L. F., West, R. B., Bacchi, L. M., van de Rijn, M., & Bacchi, C. E. (2010). DOG1 for the Diagnosis of Gastrointestinal Stromal Tumor (GIST): Comparison Between 2 Different Antibodies. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 18(4), 333-337.
  
• Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., & Chang, H. Y. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. NATURE, 464(7291), 1071-U148.
  
• Translating Gene Expression Into Clinical Care: Sarcomas As a Paradigm Nielsen, T. O., & West, R. B. (2010). Translating Gene Expression Into Clinical Care: Sarcomas As a Paradigm. JOURNAL OF CLINICAL ONCOLOGY, 28(10), 1796-1805.
  
• Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling Beck, A. H., Lee, C.-H., WITTEN, D. M., Gleason, B. C., Edris, B., & van de Rijn, M. (2010). Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. ONCOGENE, 29(6), 845-854.
  
• Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers Beck, A. H., West, R. B., & van de Rijn, M. (2010). Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers. VIRCHOWS ARCHIV, 456(2), 141-151.
  
• Meta-Mining of Gene Expression Profiles Identifies MG132 and Cantharidin as Therapeutic Agents with In Vitro Activity Against Leiomyosarcoma Edris, B., West, R. B., Lee, C. H., Zhu, M., Fletcher, J., & Beck, A. H. (2010). Meta-Mining of Gene Expression Profiles Identifies MG132 and Cantharidin as Therapeutic Agents with In Vitro Activity Against Leiomyosarcoma. LABORATORY INVESTIGATION, 90, 19A-19A.
  
• Fibroblast-Like Stromal Response Is Host-Dependent While Macrophage-Associated Stromal Response Is Tumor-Dependent: A Study of Stromal Response in Paired Breast Carcinomas from Patients with Dual Primaries Wu, J. M., Beck, A. H., WITTEN, D., Allison, K., van de Rijn, M., & West, R. B. (2010). Fibroblast-Like Stromal Response Is Host-Dependent While Macrophage-Associated Stromal Response Is Tumor-Dependent: A Study of Stromal Response in Paired Breast Carcinomas from Patients with Dual Primaries. LABORATORY INVESTIGATION, 90, 79A-79A.
  
• Histologic and Immunophenotypic Comparison of Estrogen Receptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers and Sporadic ER-Positive Breast Cancers: A Case-Control Study Kaplan, J., Schnitt, S., Collins, L., Wang, Y., Garber, J., & Tung, N. (2010). Histologic and Immunophenotypic Comparison of Estrogen Receptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers and Sporadic ER-Positive Breast Cancers: A Case-Control Study. LABORATORY INVESTIGATION, 90, 55A-55A.
  
• Variations in Stromal Signatures in Breast Cancer Metastases Webster, J. A., Beck, A. H., Sharma, M., Espinosa, I., Schreuder, M., & West, R. B. (2010). Variations in Stromal Signatures in Breast Cancer Metastases. MODERN PATHOLOGY, 23, 77A-77A.
  
• 3 '-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples Beck, A. H., Weng, Z., Witten, D. M., Zhu, S., Foley, J. W., & West, R. B. (2010). 3 '-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples. PLOS ONE, 5(1).
  
• Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours Subramanian, S., Thayanithy, V., West, R. B., Lee, C.-H., Beck, A. H., & van de Rijn, M. (2010). Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. JOURNAL OF PATHOLOGY, 220(1), 58-70.
  
• HER2 Intermediate Breast Cancers Jensen, K. C., Nielsen, T. O., Gilks, C. B., & West, R. B. (2009). HER2 Intermediate Breast Cancers. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(11), 1739-1739.
  
• Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma Krishnan, C., Higgins, J. P., West, R. B., Natkunam, Y., Heerema-McKenney, A., & Arber, D. A. (2009). Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(11), 1695-1704.
  
• EXTERNAL BEAM RADIATION THERAPY ENHANCES LOCAL CONTROL IN PIGMENTED VILLONODULAR SYNOVITIS Horoschak, M., Tran, P. T., Bachireddy, P., West, R. B., Mohler, D., & Donaldson, S. S. (2009). EXTERNAL BEAM RADIATION THERAPY ENHANCES LOCAL CONTROL IN PIGMENTED VILLONODULAR SYNOVITIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 75(1), 183-187.
  
• Expression of insulin-like growth factor 2 in mesenchymal neoplasms Steigen, S. E., Schaeffer, D. F., West, R. B., & Nielsen, T. O. (2009). Expression of insulin-like growth factor 2 in mesenchymal neoplasms. MODERN PATHOLOGY, 22(7), 914-921.
  
• Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma Espinosa, I., Beck, A. H., Lee, C.-H., Zhu, S., Montgomery, K. D., & van de Rijn, M. (2009). Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma. AMERICAN JOURNAL OF PATHOLOGY, 174(6), 2347-2356.
  
• Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract Gomez-Pinilla, P. J., Gibbons, S. J., Bardsley, M. R., Lorincz, A., Pozo, M. J., & Farrugia, G. (2009). Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 296(6), G1370-G1381.
  
• Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis Turashvili, G., Leung, S., Turbin, D., Montgomery, K., Gilks, B., & Aparicio, S. (2009). Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. BMC CANCER, 9.
  
• MOC-31 Exhibits Superior Reactivity Compared With Ber-EP4 in Invasive Lobular and Ductal Carcinoma of the Breast A Tissue Microarray Study Pai, R. K., & West, R. B. (2009). MOC-31 Exhibits Superior Reactivity Compared With Ber-EP4 in Invasive Lobular and Ductal Carcinoma of the Breast A Tissue Microarray Study. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 17(3), 202-206.
  
• LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor Ying, L., Lau, A., Alvira, C. M., West, R., Cann, G. M., & Rabinovitch, M. (2009). LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor. JOURNAL OF CELL SCIENCE, 122(9), 1441-1451.
  
• A compact VEGF signature associated with distant metastases and poor outcomes Hu, Z., Fan, C., Livasy, C., He, X., Oh, D. S., & Perou, C. M. (2009). A compact VEGF signature associated with distant metastases and poor outcomes. BMC MEDICINE, 7.
  
• The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma Beck, A. H., Espinosa, I., Edris, B., Li, R., Montgomery, K., & West, R. B. (2009). The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma. CLINICAL CANCER RESEARCH, 15(3), 778-787.
  
• The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities Gratzinger, D., Zhao, S., West, R., Rouse, R. V., Vogel, H., & Natkunam, Y. (2009). The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(2), 264-278.
  
• Discovery of Molecular Subtypes in Leiomyosarcoma through Integrative Molecular Profiling Beck, A. H., Lee, C. H., WITTEN, D. M., Zhou, S., Montgomery, K., & van de Rijn, M. (2009). Discovery of Molecular Subtypes in Leiomyosarcoma through Integrative Molecular Profiling. LABORATORY INVESTIGATION, 89, 368A-368A.
  
• Discovery of Molecular Subtypes in Leiomyosarcoma through Integrative Molecular Profiling Beck, A. H., Lee, C. H., WITTEN, D. M., Zhou, S., Montgomery, K., & van de Rijn, M. (2009). Discovery of Molecular Subtypes in Leiomyosarcoma through Integrative Molecular Profiling. MODERN PATHOLOGY, 22, 368A-368A.
  
• CSF-1 and Fibromatosis Expression in Stroma of Ductal Carcinoma In Situ Sharma, M., Espinosa, I., Beck, A. H., Webster, J. A., Montgomery, K. D., & West, R. B. (2009). CSF-1 and Fibromatosis Expression in Stroma of Ductal Carcinoma In Situ. LABORATORY INVESTIGATION, 89, 67A-67A.
  
• Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue Jensen, K. C., Schaeffer, D. F., Cheang, M., Montgomery, K., West, R. B., & van de Rijn, M. (2008). Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue. MODERN PATHOLOGY, 21(12), 1413-1420.
  
• New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up Jensen, K. C., Turbin, D. A., Leung, S., Miller, M. A., Johnson, K., & West, R. B. (2008). New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up. BREAST CANCER RESEARCH AND TREATMENT, 112(3), 453-459.
  
• KIT Gene Mutations and Copy Number in Melanoma Subtypes Beadling, C., Jacobson-Dunlop, E., Hodi, F. S., Le, C., Warrick, A., & Corless, C. L. (2008). KIT Gene Mutations and Copy Number in Melanoma Subtypes. CLINICAL CANCER RESEARCH, 14(21), 6821-6828.
  
• Immunohistochemical and Biogenetic Features of Diffuse-Type Tenosynovial Giant Cell Tumors: The Potential Roles of Cyclin A, P53, and Deletion of 15q in Sarcomatous Transformation Huang, H.-Y., West, R. B., Tzeng, C.-C., van de Rijn, M., Wang, J.-W., & Li, C.-F. (2008). Immunohistochemical and Biogenetic Features of Diffuse-Type Tenosynovial Giant Cell Tumors: The Potential Roles of Cyclin A, P53, and Deletion of 15q in Sarcomatous Transformation. CLINICAL CANCER RESEARCH, 14(19), 6023-6032.
  
• Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms Jokinen, C. H., Dadras, S. S., Goldblum, J. R., van de Rijn, M., West, R. B., & Rubin, B. P. (2008). Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 129(6), 886-893.
  
• The fibromatosis signature defines a robust stromal response in breast carcinoma Beck, A. H., Espinosa, I., Gilks, C. B., van de Rijn, M., & West, R. B. (2008). The fibromatosis signature defines a robust stromal response in breast carcinoma. LABORATORY INVESTIGATION, 88(6), 591-601.
  
• Predictive value of tumor associated histiocytes in patients with leiomyosarcoma Ganjoo, K. N., WITTEN, D., Patel, M., Espinosa, I., La, T., & van de Rijn, M. (2008). Predictive value of tumor associated histiocytes in patients with leiomyosarcoma. JOURNAL OF CLINICAL ONCOLOGY, 26(15).
  
• Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone Lee, C.-H., Espinosa, I., Jensen, K. C., Subramanian, S., Zhu, S. X., & West, R. B. (2008). Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. MODERN PATHOLOGY, 21(5), 531-539.
  
• Prognostic significance of macrophage infiltration in leiomyosarcomas Lee, C.-H., Espinosa, I., Vrijaldenhoven, S., Subramanian, S., Montgomery, K. D., & van de Rijn, M. (2008). Prognostic significance of macrophage infiltration in leiomyosarcomas. CLINICAL CANCER RESEARCH, 14(5), 1423-1430.
  
• A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors Espinosa, I., Lee, C.-H., Kim, M. K., Rouse, B.-T., Subramanian, S., & van de Rijn, M. (2008). A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(2), 210-218.
  
• The Stanford Tissue Microarray Database Marinelli, R. J., Montgomery, K., Liu, C. L., Shah, N. H., Prapong, W., & Ball, C. A. (2008). The Stanford Tissue Microarray Database. NUCLEIC ACIDS RESEARCH, 36, D871-D877.
  
• The CSF-1 response signature in breast carcinoma Beck, A. B., Espinosa, I., van de Rijn, M., & West, R. B. (2008). The CSF-1 response signature in breast carcinoma. MODERN PATHOLOGY, 21, 22A-22A.
  
• A novel breast carcinoma stromal response defined by the Nodular Fasciitis gene signature Cho, N. K., Beck, A. H., Espinosa, I., Montgomery, K., Zhu, S., & West, R. B. (2008). A novel breast carcinoma stromal response defined by the Nodular Fasciitis gene signature. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 72(1), S686-S686.
  
• HER2 status in a large, population-based cohort: Analysis of distinct HER2 subgroups Jensen, K. C., Turbin, D. A., Leung, S., Miller, M. A., Johnson, K., & West, R. B. (2008). HER2 status in a large, population-based cohort: Analysis of distinct HER2 subgroups. LABORATORY INVESTIGATION, 88, 39A-39A.
  
• Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis West, R. B., & De Rijn, M. V. (2007). Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. LABORATORY INVESTIGATION, 87(10), 967-970.
  
• Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides Cupp, J. S., Miller, M. A., Montgomery, K. D., Nielsen, T. O., O'Connell, J. X., & West, R. B. (2007). Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 31(6), 970-976.
  
• Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors Lehman, N. L., Tibshirani, R., Hsu, J. Y., Natkunam, Y., Harris, B. T., & Jackson, P. K. (2007). Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. AMERICAN JOURNAL OF PATHOLOGY, 170(5), 1793-1805.
  
• Comparison of a new mouse monoclonal Anti-HER2/neu antibody to a rabbit polyclonal antibody Turbin, D. A., Jensen, K., Leung, S., McKinney, S. E., Huntsman, D. G., & West, R. B. (2007). Comparison of a new mouse monoclonal Anti-HER2/neu antibody to a rabbit polyclonal antibody. LABORATORY INVESTIGATION, 87, 52A-52A.
  
• Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus Troxell, M. L., Bangs, C. D., Lawce, H. J., Galperin, I. B., Baiyee, D., & Cherry, A. M. (2006). Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 126(5), 709-716.
  
• Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation Sneddon, J. B., Zhen, H. H., Montgomery, K., van de Rijn, M., Tward, A. D., & Brown, P. O. (2006). Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(40), 14842-14847.
  
• Upregulation of histidine decarboxylase expression in superficial cortical nephrons during pregnancy in mice and women Morgan, T. K., Montgomery, K., Mason, V., West, R. B., Wang, L., & Higgins, J. P. (2006). Upregulation of histidine decarboxylase expression in superficial cortical nephrons during pregnancy in mice and women. KIDNEY INTERNATIONAL, 70(2), 306-314.
  
• A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells West, R. B., Rubin, B. P., Miller, M. A., Subramanian, S., Kaygusuz, G., & van de Rijn, M. (2006). A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(3), 690-695.
  
• Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumors, and reactive synovial lesions Cupp, J. S., Rubin, B. P., Miller, M. A., Subramanian, S., Montgomery, K., & West, R. B. (2006). Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumors, and reactive synovial lesions. MODERN PATHOLOGY, 19, 10A-10A.
  
• Epidermal growth factor receptor (EGFR) expression and gene amplification in a spectrum of spindle cell soft tissue neoplasms: A fluorescence in situ hybridization (FISH) and immunohistochemical (IHC) study Larson, A. J., Downs-Kelley, E., Skacel, M., Tubbs, R. R., Rubin, B. P., & Goldblum, J. R. (2006). Epidermal growth factor receptor (EGFR) expression and gene amplification in a spectrum of spindle cell soft tissue neoplasms: A fluorescence in situ hybridization (FISH) and immunohistochemical (IHC) study. MODERN PATHOLOGY, 19, 14A-14A.
  
• Heat-shock protein-90 (HSP-90) expression in a spectrum of benign and malignant spindle cell neoplasms: An immunohistochemical study Larson, A. J., Downs-Kelley, E., Skacel, M., Nielsen, T. O., Ruttan, C., & Goldblum, J. R. (2006). Heat-shock protein-90 (HSP-90) expression in a spectrum of benign and malignant spindle cell neoplasms: An immunohistochemical study. LABORATORY INVESTIGATION, 86, 13A-14A.
  
• The role of microarray technologies in the study of soft tissue tumours West, R. B., & van de Rijn, M. (2006). The role of microarray technologies in the study of soft tissue tumours. HISTOPATHOLOGY, 48(1), 22-31.
  
• TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays Liu, C. L., Montgomery, K. D., Natkunam, Y., West, R. B., Nielsen, T. O., & Higgins, J. Pt. (2005). TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays. MODERN PATHOLOGY, 18(12), 1641-1648.
  
• The gene expression profile of extraskeletal myxoid chondrosarcoma Subramanian, S., West, R. B., Marinelli, R. J., Nielsen, T. O., Rubin, B. P., & van de Rijn, M. (2005). The gene expression profile of extraskeletal myxoid chondrosarcoma. JOURNAL OF PATHOLOGY, 206(4), 433-444.
  
• Determination of stromal signatures in breast carcinoma West, R. B., Nuyten, D. Sa., Subramanian, S., Nielsen, T. O., Corless, C. L., & van de Rijn, M. (2005). Determination of stromal signatures in breast carcinoma. PLOS BIOLOGY, 3(6), 1101-1110.
  
• Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage Nguyen, T. Dt., Schwartz, E. J., West, R. B., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2005). Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 29(5), 617-624.
  
• Novel gene ANKS1 expression in gastrointestinal stromal tumors Kalof, A. N., West, R. B., Subramanian, S., Zhu, S., Montgomery, K., & Van vde Rijn, M. (2005). Novel gene ANKS1 expression in gastrointestinal stromal tumors. MODERN PATHOLOGY, 18, 16A-16A.
  
• Nuclear beta-catenin in mesenchymal tumors Ng, T. L., GOWN, A. M., Barry, T. S., Cheang, M. Cu., Chan, A. Kw., & Nielsen, T. O. (2005). Nuclear beta-catenin in mesenchymal tumors. MODERN PATHOLOGY, 18(1), 68-74.
  
• Characterization of anti-fatty acid synthase expression in normal breast and breast cancer. Jensen, K. C., Montgomery, K., West, R. B., & van de Rijn, J. M. (2005). Characterization of anti-fatty acid synthase expression in normal breast and breast cancer. BREAST CANCER RESEARCH AND TREATMENT, 94, S282-S282.
  
• CSF1R expression in soft tissue tumors West, R. B., Kaygusuz, G., Subramanian, S., Corless, C. L., Rubin, B. P., & Brown, P. O. (2005). CSF1R expression in soft tissue tumors. MODERN PATHOLOGY, 18, 23A-23A.
  
• CSF1 expression signature identifies a subset of breast carcinomas and influences outcome. West, R. B., Horlings, H., Nuyten, D. Sa., Subramanian, S., Zhu, S. X., & van de Rijn, M. (2005). CSF1 expression signature identifies a subset of breast carcinomas and influences outcome. BREAST CANCER RESEARCH AND TREATMENT, 94, S135-S135.
  
• Stromal expression signatures predict outcome in breast carcinoma West, R. B., Nuyten, D. Sa., Subramanian, S., Corless, C., Rubin, B. P., & van de Rijn, M. (2005). Stromal expression signatures predict outcome in breast carcinoma. LABORATORY INVESTIGATION, 85, 55A-55A.
  
• Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles Subramanian, S., West, R. B., Corless, C. L., Ou, W. B., Rubin, B. P., & van de Rijn, M. (2004). Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles. ONCOGENE, 23(47), 7780-7790.
  
• Apo D in soft tissue tumors - A novel marker for dermatofibrosarcoma protuberans West, R. B., Harvell, J., Linn, S. C., Lui, C. L., Prapong, W., & van de Rijn, M. (2004). Apo D in soft tissue tumors - A novel marker for dermatofibrosarcoma protuberans. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 28(8), 1063-1069.
  
• CD117 expression in mesothelioma Arber, D. A., Weiss, L. M., & West, R. B. (2004). CD117 expression in mesothelioma. MODERN PATHOLOGY, 17(8), 1021-1021.
  
• The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status West, R. B., Corless, C. L., Chen, X., Rubin, B. P., Subramanian, S., & van de Rijn, M. (2004). The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. AMERICAN JOURNAL OF PATHOLOGY, 165(1), 107-113.
  
• Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., & Brown, P. O. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS biology, 2(2), E7-?.
  
• Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., & Brown, P. O. (2004). Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLOS BIOLOGY, 2(2), 206-214.
  
• Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans Linn, S. C., West, R. B., Pollack, J. R., Zhu, S., Hernandez-Boussard, T., & van de Rijn, M. (2003). Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. AMERICAN JOURNAL OF PATHOLOGY, 163(6), 2383-2395.
  
• Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology Nielsen, T. O., Hsu, F. D., O'Connell, J. X., Gilks, C. B., Sorensen, P. Hb., & van de Rijn, M. (2003). Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. AMERICAN JOURNAL OF PATHOLOGY, 163(4), 1449-1456.
  
• Array-based comparative genomic hybridization (ACGH) of dermatofibrosarcoma protuberans (DFSP) on cDNA micorarrays using DNA isolated from fresh frozen and paraffin embedded tissue Jensen, K., West, R. B., Zhu, S. X., Linn, S. C., Nielsen, T. O., & van de Rijn, M. (2003). Array-based comparative genomic hybridization (ACGH) of dermatofibrosarcoma protuberans (DFSP) on cDNA micorarrays using DNA isolated from fresh frozen and paraffin embedded tissue. LABORATORY INVESTIGATION, 83(1), 15A-15A.
  
• Expression profiling of fibromatosis by cDNA gene array analysis Cheng, L., West, R. B., Zhu, S., Linn, S. C., Nielsen, T. O., & van de Rijn, M. (2003). Expression profiling of fibromatosis by cDNA gene array analysis. MODERN PATHOLOGY, 16(1), 10A-10A.
  
• Array-based comparative genomic hybridization (ACGH) of dermatofibrosarconta protuberans (DFSP) on cDNA micorarrays using DNA isolated from fresh frozen and paraffin embedded tissue Jensen, K., West, R. B., Zhu, S. X., Linn, S. C., Nielsen, T. O., & van de Rijn, M. (2003). Array-based comparative genomic hybridization (ACGH) of dermatofibrosarconta protuberans (DFSP) on cDNA micorarrays using DNA isolated from fresh frozen and paraffin embedded tissue. MODERN PATHOLOGY, 16(1), 15A-15A.
  
• Novel gene FLJ10261 in gastrointestinal stromal tumors West, R. B., Linn, S. C., Nielsen, T. O., Montgomery, K., Goldblum, J. R., & van de Rijn, M. (2003). Novel gene FLJ10261 in gastrointestinal stromal tumors. MODERN PATHOLOGY, 16(1), 20A-20A.
  
• Molecular characterisation of soft tissue tumours: a gene expression study Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., & van de Rijn, M. (2002). Molecular characterisation of soft tissue tumours: a gene expression study. LANCET, 359(9314), 1301-1307.
  
• The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens West, R. B., Warnke, R. A., & Natkunam, Y. (2002). The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 117(4), 636-643.
  
• The mRNA expression signature of solitary fibrous tumors West, R. B., Linn, S. C., Foxman, E., Neilson, T., Zhu, S., & van de Rijn, M. (2002). The mRNA expression signature of solitary fibrous tumors. LABORATORY INVESTIGATION, 82(1), 24A-24A.
  
• Tissue Microarray analysis of known and novel synovial sarcoma markers Nielsen, T. O., O'Connell, J. X., Hsu, F. D., West, R. B., Linn, S. C., & van de Rijn, M. (2002). Tissue Microarray analysis of known and novel synovial sarcoma markers. LABORATORY INVESTIGATION, 82(1), 20A-20A.
  
• Genome-wide mRNA expression profiling of dermatofibrosarcoma protuberans using cDNA microarrays Linn, S. C., West, R. B., Zhu, S., Nielsen, T., Goldblum, J. R., & van de Rijn, M. (2002). Genome-wide mRNA expression profiling of dermatofibrosarcoma protuberans using cDNA microarrays. MODERN PATHOLOGY, 15(1), 18A-18A.
  
• Tissue microarray analysis of CD44, p53, Ki-67 and bcl-2 as prognostic markers in rhabdomyosarcoma Linn, S. C., West, R. B., Wijnaendts, L. C., Montgomery, K., Mitchell, J., & van de Rijn, M. (2002). Tissue microarray analysis of CD44, p53, Ki-67 and bcl-2 as prognostic markers in rhabdomyosarcoma. MODERN PATHOLOGY, 15(1), 312A-313A.
  
• Distinction between low grade endometrial stromal sarcoma and smooth muscle tumors by cDNA gene array analysis West, R. B., Linn, S. C., Nielsen, T., Zhu, S., Longacre, T., & van de Rijn, M. (2002). Distinction between low grade endometrial stromal sarcoma and smooth muscle tumors by cDNA gene array analysis. LABORATORY INVESTIGATION, 82(1), 213A-214A.
  
• The RAG-HMG1 complex enforces the 12/23 rule of V(D)J recombination specifically at the double-hairpin formation step West, R. B., & Lieber, M. R. (1998). The RAG-HMG1 complex enforces the 12/23 rule of V(D)J recombination specifically at the double-hairpin formation step. MOLECULAR AND CELLULAR BIOLOGY, 18(11), 6408-6415.
  
• Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini West, R. B., Yaneva, M., & Lieber, M. R. (1998). Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini. MOLECULAR AND CELLULAR BIOLOGY, 18(10), 5908-5920.
  
• Antigen receptor gene rearrangement Grawunder, U., West, R. B., & Lieber, M. R. (1998). Antigen receptor gene rearrangement. CURRENT OPINION IN IMMUNOLOGY, 10(2), 172-180.